N E W S Correction

NEWS
Correction
Due to a typesetter’s error, the
incorrect version of the third paragraph
from the end of “Tamoxifen Pharmacogenetics Moves Closer to Reality” (Vol.
97, No. 6, p. 412) was printed. The
fourth sentence should read as follows:
“He points out that the response rate for
Herceptin (trastuzumab) is only 25%,
even for patients with multiple copies of
the Her-2/neu gene.”
480
NEWS
Journal of the National Cancer Institute, Vol. 97, No. 7, April 6, 2005